David Páez1,2. Show Affiliations » 1. Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. 2. CIBERER U-705, Barcelona, Spain.
Abstract
Entities: Chemical
Mesh： See more » Antineoplastic Combined Chemotherapy Protocols/adverse effectsAntineoplastic Combined Chemotherapy Protocols/therapeutic useDrug-Related Side Effects and Adverse Reactions/geneticsGeneticsGenotypeHumansIrinotecan/adverse effectsIrinotecan/therapeutic useNeoplasms/drug therapyNeoplasms/geneticsTopoisomerase I Inhibitors/adverse effectsTopoisomerase I Inhibitors/therapeutic use
Substances： See more » Topoisomerase I InhibitorsIrinotecan
Year: 2019 PMID： 31117929 DOI： 10.2217/pgs-2019-0012
Source DB: PubMed Journal: Pharmacogenomics ISSN： 1462-2416 Impact factor: 2.533